Mariner’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-46,580
Closed -$883K 3788
2025
Q4
$883K Buy
46,580
+21,949
+89% +$407K ﹤0.01% 2037
2025
Q3
$459K Buy
24,631
+7,271
+42% +$136K ﹤0.01% 2501
2025
Q2
$320K Buy
17,360
+4,774
+38% +$84.7K ﹤0.01% 2678
2025
Q1
$220K Buy
12,586
+1,381
+12% +$23.3K ﹤0.01% 2927
2024
Q4
$194K Buy
+11,205
New +$205K ﹤0.01% 3015
2023
Q4
Sell
-10,622
Closed -$148K 3164
2023
Q3
$148K Buy
+10,622
New +$136K ﹤0.01% 2605
2019
Q3
Sell
-10,026
Closed -$197K 981
2019
Q2
$197K Sell
10,026
-23,566
-70% -$459K ﹤0.01% 1049
2019
Q1
$654K Buy
33,592
+7,972
+31% +$151K 0.01% 588
2018
Q4
$422K Buy
+25,620
New +$516K 0.01% 609

Other funds holding SBRA

Mariner's SBRA Position: Q1 2026 in Review

Mariner sold out of Sabra Healthcare REIT (SBRA) in Q1 2026, closing a stake of 46,580 shares — an estimated $883K sold.

Mariner first reported a position in SBRA in Q4 2018 and held it in 9 quarters. The position peaked at $883K in Q4 2025. 463 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Mariner reported no remaining Sabra Healthcare REIT position as of Q1 2026 after selling out during the quarter.
  • Mariner sold 46,580 Sabra Healthcare REIT shares in Q1 2026, an estimated $883K.
  • Mariner first reported a position in Sabra Healthcare REIT in Q4 2018 and held it in 9 quarters.
  • Mariner's Sabra Healthcare REIT position peaked at $883K in Q4 2025.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.